Loading
New 'Ella' drug should be labeled an abortion pill, argues pro-life leader
Steve Mosher

.- In response to the FDA's safety approval of a new drug being described as a “morning-after” pill, a pro-life leader denounced the drug as an abortifacient, and argued that it needs to be labeled accurately.

The FDA is slated to meet on Thursday to discuss whether or not “Ella” – which is currently being marketed abroad as a “morning-after” pill  – should be approved for U.S. distribution. The drug has received criticism from numerous sources who have claimed the pill's chemical make-up closely resembles the abortion drug RU-486.

One such critic, Steve Mosher, director of Population Research Institute, told CNA on Thursday that “greed” on the part of the pharmaceutical company is one of the major factors in the situation, given that distribution of the drug would be limited were it labeled an abortifacient. Mosher also claims that word “pregnancy” is being redefined by the company in order to suit their corporate interests.

“There is little doubt that the 'Ella' pill acts as an abortifacient in nearly all cases,” wrote Mosher in an email to CNA on Thursday. “The only reason that the company claims otherwise – aside from greed, that is – is that they redefine the meaning of the word 'pregnant.'” 

“In their view, pregnancy does not begin at conception, but rather only at the implantation of the developing embryo into the uterine wall five to seven days later,” he noted. “This is a misleading and inaccurate definition of pregnancy.”

“Planned Parenthood – an organization that would profit off the new drug – claims that there is no evidence that the drug interrupts pregnancy after implantation.” 

“But it almost surely does,” he explained, “since it blocks the progesterone receptors necessary for the early development of the embryo to continue.” 

“Indeed, the test which women are given to determine whether they are suffering a miscarriage is one which measures the amount of progesterone,” the pro-life leader clarified. “A progesterone-killing drug will also necessarily be an embryo-killing drug.”

“This is another kind of abortion pill and should be clearly labeled as such if it is approved at all,” Mosher asserted.

* The number of messages that can be online is limited. CNA reserves the right to edit messages for content and tone. Comments and opinions expressed by users do not necessarily reflect the opinions or beliefs of CNA. CNA will not publish comments with abusive language, insults or links to other pages

RESOURCES »

Featured Videos

Group launches tour to end abortion in Canada
Group launches tour to end abortion in Canada
Actor admires Mexican martyr's strong defense of the faith
First video game about Jesus launches on Facebook
Vandals strike historic Santa Cruz church
EU accused of funding abortion with development money
Brent Dusing's advice to Internet Evangelists
Creator of Bible-based Facebook game lauds internet evangelism
Sacrifice of Titanic's Catholic priests recalled on 100th anniversary
Benedict XVI visits the Shrine of the Virgin of Cobre and meets President Raul Castro
Vestments for Pope's Mass in Cuba arrive with love from Peru
Pope Benedict XVI in Antonio Maceo Square in Santiago de Cuba
Benedict XVI meets with President Calderon and Mexican children
Americans speak up for religious freedom at nationwide rallies
Neighborhood rallies against plan to build strip club near convent
Pope's first Mexican address offers encouragement to faithful
Arrival of  Pope Benedict XVI  to Mexico
Pope offers his blessing to handicapped children in Mexico
Texas bishops hear call to unity at St. Peter's tomb
Interview with Br. Guy Consolmagno
Indiana Catholics respond to 'devastating' storm damage
May
25

Liturgical Calendar

May 25, 2012



All readings:
Today »
This year »

Catholic Daily

Gospel of the Day

Jn 21,15-19

Gospel
Date
05/25/12
05/24/12
05/23/12

Daily Readings


First Reading:: Acts 25:13b-21
Gospel:: Jn 21:15-19

Homily of the Day

Jn 21,15-19

Homily
Date
05/25/12
05/24/12
05/23/12
     HTML
Text only
Headlines
  

Follow us: